Creatine monohydrate in DM2/PROMM: A double-blind placebo-controlled clinical study

Neurology

Volumn 60, Issue 3, 2003, Pages 500-502

  Schneider Gold, Christiane ^a   Beck, M ^a   Wessig, C ^a   George, A ^a   Kele, H ^b   Reiners, K ^a   Toyka, K V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREAPURE; CREATINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYNAMOMETRY; FEMALE; GRIP STRENGTH; HUMAN; MALE; MUSCLE STRENGTH; MYALGIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0037432120     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000044405.29988.E1     Document Type: Article

References (10)

1. Moxley RT, Udd B, Ricker K. Report of the 84th ENMC Workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes. Neuromusc Disord 2002;12:306-317.
2. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 is caused by a CCTG repeat expansion in intron 1 of ZNF9. Science 2001; 239:864-867.
3. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992;83:367-374.
4. Tarnopolsky MA, Mac Lennan DP. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab 2000;10:452-463.
5. Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular diseases. Neurology 1999;52:854-857.
6. Walter MC, Lochmüller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: a double blind, placebo-controlled clinical study. Neurology 2000;54:1848-1850.
7. Tarnopolsky MA, Parise G. Direct measurement of high energy phosphate compounds in patients with neuromuscular diseases. Muscle Nerve 1999;22:1502-1509.
8. Tarnopolsky MA, Parshad A, Walzel B, Schlattner U, Wallimann T. Creatine transporter and mitochondrial creatine kinase protein content in myopathies. Muscle Nerve 2001;24:682-688.
9. Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001;53:161-176.
10. Passaquin AC, Renard M, Kay L, et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromusc Disord 2002;12:174-182.